Skip to content

The Northstar Trial

Assessing the Accuracy of Catheter Localization With NorthStar Software in Real-Time MRI-Guided Cardiac Ablation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06359678
Acronym
Northstar
Enrollment
20
Registered
2024-04-11
Start date
2024-01-01
Completion date
2025-01-01
Last updated
2024-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flutter, Atrial

Brief summary

The introduction of real-time MRI-guided cardiac ablation therapy, a significant advancement in interventional medicine, necessitates precise catheter tracking for accurate navigation within the complex cardiac anatomy. The introduction of the NorthStar software as an active tracking system holds promise for improving the precision and efficiency of catheter manipulation during these procedures. However, a rigorous evaluation of its accuracy and reliability in a clinical setting is crucial to validate its viability. The objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during real-time MRI-guided cardiac ablation therapy.

Interventions

DEVICENorthStar

Throughout the real-time MRI-guided ablation procedure, the operator will assess the precision of the NorthStar 3D navigation software. Before commencing the actual ablation, the operator will confirm the alignment of the 3D anatomical shell, generated in NorthStar through specific electrical signals. Post the ablation procedure, a secondary alignment verification will be conducted to detect any potential drift or shift.

Sponsors

Amsterdam UMC, location VUmc
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing a real-time MRI-guided flutter ablation procedure at the Amsterdam UMC.

Exclusion criteria

* Lack of legal capacity. * Insufficient proficiency in the Dutch language.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Catheter Localizationduring procedureThe primary objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during realtime MRI-guided cardiac ablation therapy. At the start of the procedure, the catheters will be manoeuvred to the predefined areas within the right side of the heart based on the specific electrical signals in that area. These locations will be virtually marked within the NorthStar software. The extent to which these markers maintain their spatial coordinates after the ablation procedure, evaluated by obtained electrical signals, will serve as a quantitative measure of the system's accuracy.

Secondary

MeasureTime frameDescription
Influences of breathing patternduring procedureTo investigate the influence of breathing pattern on the accuracy of catheter localization. The breathing pattern during the procedure will be monitored and any changes will be related to the accuracy of catheter localization
Influences of procedure durationduring procedureTo investigate the influence of procedure duration on the accuracy of catheter localization.
Influences of complications during ablationduring procedureTo investigate the influence of complications during ablation on the accuracy of catheter localization. Complications during the procedure will be registered and categorized.
Influences of patient characteristicsduring procedureTo investigate the influence of patient characteristics on the accuracy of catheter localization. Standard patient characteristics will be noted such as BMI, cardiac output and heartrate to investigate if these characteristics will influence the catheter localization.

Countries

Netherlands

Contacts

Primary ContactMarco Gotte
mjw.gotte@amsterdamumc.nl020-44440123
Backup ContactLuuk Hopman
l.hopman@amsterdamumc.nl020-44441405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026